Top 3 Must-Buy Cryptos for 2025: Why XRP Didn’t Make the List Even After the SEC Lawsuit Ending
The post Top 3 Must-Buy Cryptos for 2025: Why XRP Didn’t Make the List Even After the SEC Lawsuit Ending appeared on BitcoinEthereumNews.com.
Rexas Finance, Hyperliquid, and Pepe Coin stand out as the top three must-buy cryptos for 2025. Rexas Finance is poised for explosive gains, with its token launch nearing and its trajectory painting a bullish picture. Hyperliquid is gaining momentum in the DeFi space, with its perpetual trading platform attracting strong investor confidence. IMeanwhile, Pepe Coin continues to defy expectations. Its whale accumulation and bullish technical indicators suggests a potential rally. However, despite Ripple’s win against the SEC, it doesn’t make the list because its price action has remained underwhelming. Investors expected regulatory clarity to ignite a strong rally. However, XRP has struggled to break key resistance levels. On-chain data also reflects a lack of enthusiasm, as there has been no sharp influx of new participants. Thus, XRP may not be an excellent choice for investors targeting exponential returns in 2025. The three cryptos below offer better potential in the current market cycle. Rexas Finance (RXS): The Future of Real-World Asset Tokenization Rexas Finance’s focus on real-world asset (RWA) tokenization drives massive interest from retail and institutional investors. The project allows investors to own fractional shares of tangible and intangible assets like real estate and intellectual property. This makes investing more accessible, removing barriers that typically restrict entrance into the market. Rexas Finance turns these assets into digital tokens, bringing traditional assets into the blockchain space. Hence, Rexas Finance is poised to transform how people invest in the real world. The project’s presale has been incredibly successful, raising over $47.5 million and selling nearly all available tokens. Investors are eager to get in early, as the official token launch is expected to trigger a major price surge. The official listing price of RXS will be $0.25, but analysts predict it could skyrocket post-launch due to high demand and strong momentum. Some…
Filed under: News - @ April 13, 2025 5:24 pm